The coronavirus drug developed by Pfizer entered the process of getting approval in the USA. It was announced that the drug called Paxlovid, which will be used if the FDA approves, is 89 percent effective in preventing hospitalization and deaths.
A new one has been added to the developments that have the potential to remove the coronavirus pandemic from our agenda. Making history by developing a coronavirus vaccine with BioNTech PfizerThis time, he applied to the US Food and Drug Administration (FDA) for the COVID-19 drug he developed. your drug emergency use approval It seems that it can change many situations related to the pandemic.
The drug with the code “PF-07321332” developed by Pfizer is at the point of preventing hospitalization and deaths. 89 percent rate effective. Developed thanks to an investment of 1 billion dollars and “PaxlovidIf the drug, named “, is approved, it will be launched as the second COVID-19 drug. Merck‘s coronavirus drug developed in the UK by consent was made available.
Pfizer will apply for use permits in many countries
In statements made by Pfizer, the application for approval only It won’t be just the FDA specified. In addition to the USA, the company will apply to health authorities in countries such as New Zealand, South Korea, England and Australia. In this way, the drug will be spread all over the world. Company, for Turkey Didn’t make any reviews.
RELATED NEWS
Outbreak in the Zoo: 3 Snow Leopards Died in the USA due to Coronavirus
In the statements made by Pfizer CEO Albert Bourla, life saving Emphasis was placed on the need for treatment. Stating that this drug is exactly this treatment method, the CEO said that they expect support from regulatory institutions and that they are looking for Paxlovid. must be acted quickly told. We will see more clearly what will happen with the drug in the coming days…
Source :
https://www.sozcu.com.tr/2021/saglik/pfizer-corona-ilacinin-acil-egitimimi-icin-fdaya-basvurdu-6773051/